IRCT20161122031016N2
Completed
Phase 3
Comparison of the Effectiveness of Pharmacotherapy and Neurofeedback on Improving Executive Functions and Externalizing Behavior Disorders in children with attention deficit-hyperactivity disorder
Islamic Azad University, Rasht Branch0 sites45 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Islamic Azad University, Rasht Branch
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Receiving written consent from parents and informed consent of the child
- •gender (boy)
- •age range (8 to 12 years)
- •Average IQ (90 to 109\) based on the Wechsler IQ test that is recorded in the child's file and clinical observations recorded by experts
- •definitive diagnosis of Attention Deficit Hyperactivity Disorder based on the criteria of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders by a pediatric psychiatrist and child and adolescent clinical psychologist
- •obtaining the necessary cut score in the Behavior Rating Inventory of Executive Function (BRIEF), Gerard et al. (2000\), and Achenbach's Child Behavior Checklist (CBCL), Achenbach (2001\) for all three groups (two experimental groups and one control group)
Exclusion Criteria
- •Suffering from neurological\-developmental or other psychological disorders at the same time
- •receiving other medical and psychological interventions at the same time
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Comparision of the efficacy of pharmacotherapy and combination of pharmacotherapy with transdiagnostic cognitive-behavior therapy on anxiety and depression symptoms in patients with emotional disordersIRCT20181019041385N1The university of kurdestan29
Completed
Not Applicable
children enuresisnocturnal enuresis.Nonorganic enuresisIRCT2014102719702N1Ahvaz Jundishapur University of Medical Sciences64
Recruiting
Phase 3
Comparison of the effectiveness of pharmacotherapy with sertraline versus Glaser reality therapy in social anxiety disorderSocial anxiety.Anxiety disorder due to known physiological conditionF06.4IRCT20191106045356N4Yazd University of Medical Sciences75
Not yet recruiting
Phase 3
Evaluation of the effects of sertraline and Acceptance and Commitment Therapy (ACT) enriched with Compassion Focus Therapy (CFT) on depression, stress, and anxietyIRCT20191106045356N1Yazd University of Medical Sciences60
Recruiting
Phase 3
Evaluation of the effects of venlafaxine and Acceptance and Commitment Therapy (ACT) enriched with Compassion Focus Therapy (CFT) on depression, stress, and anxietyin addict patients undergoing Methadone Maintenance Therapy.Mood disorder due to known physiological condition with depressive featuresF06.31IRCT20191106045356N3Yazd University of Medical Sciences60